Free Trial

Bid Underpinned


Firmer On North Korean Missile Launch

Real-time Actionable Insight

Get the latest on Central Bank Policy and FX & FI Markets to help inform both your strategic and tactical decision-making.

Free Access
PIPELINE: Still no new high-grade issuance for the day after near $25B issued by
Wed. AbbVie history
Date $MM Issuer/Rating/Desc/Maturity/Yld; Priced *; Launch #:
11/07 Nothing in the works as yet
11/?? Chatter: AbbVie jumbo issue next week? (last year, AbbVie issued $6B on
09/13: 1.25B 3Y +60, $1.25B 5Y +90, $1.75B 10Y +138, $1.75B 30Y +183)
11/?? Chatter: Sprint
11/?? Chatter: T-Mobile US 

To read the full story

Why Subscribe to

MNI is the leading provider

of news and intelligence specifically for the Global Foreign Exchange and Fixed Income Markets, providing timely, relevant, and critical insight for market professionals and those who want to make informed investment decisions. We offer not simply news, but news analysis, linking breaking news to the effects on capital markets. Our exclusive information and intelligence moves markets.

Our credibility

for delivering mission-critical information has been built over three decades. The quality and experience of MNI's team of analysts and reporters across America, Asia and Europe truly sets us apart. Our Markets team includes former fixed-income specialists, currency traders, economists and strategists, who are able to combine expertise on macro economics, financial markets, and political risk to give a comprehensive and holistic insight on global markets.